Medication-Assisted Treatment (MAT) in Florida

Recovery from opioid use disorder does not always mean avoiding medication. For some people, the right medication can reduce cravings, limit the effects of opioids or provide enough stability to engage more consistently in treatment and everyday recovery. The more useful question is whether medication-assisted treatment has a role in your treatment. At Bright Futures Treatment Center, that decision is made with medical oversight and considered alongside the therapy, mental health support and level of care each client needs.

What Is Medication-Assisted Treatment at Bright Futures?

Medication-Assisted Treatment, or MAT, uses approved medication as part of care for a substance use disorder. At Bright Futures, our current MAT services are part of treatment for opioid use disorder (OUD), with medication considered after the medical and clinical team has reviewed the client’s circumstances.

Depending on the treatment plan, MAT may involve buprenorphine/naloxone, commonly known by the brand name Suboxone, or naltrexone. It can also be part of individual therapy, group treatment, mental health care and other recovery services rather than functioning as a separate program by itself.

You may also encounter the term medications for opioid use disorder (MOUD). MOUD refers specifically to medications used in opioid treatment, while MAT has traditionally been used more broadly for medication combined with behavioral health services. Both terms may appear in discussions of opioid recovery, but medication itself remains an evidence-based part of treatment rather than simply an add-on to therapy.

Who May Benefit From MAT?

MAT often becomes part of the conversation when opioid cravings, repeated return to use or difficulty maintaining stability continue to interfere with recovery. Some clients come to us after prolonged heroin or prescription-opioid use. Others have already attempted recovery without medication or are moving into ongoing addiction treatment after a period of stabilization. These experiences can make medication worth considering, but they do not automatically determine which option will be appropriate.

Opioid-use history, physical and mental health, previous experience with treatment and other medications all influence the decision. MAT is also not automatically appropriate for every substance use disorder or every person entering treatment.

Rather than asking clients to arrive knowing which medication they want, our role is to determine whether medication can support treatment and, if so, which approach makes sense medically.

Medications Used in MAT

The medications used for opioid use disorder do not all work in the same way. That difference affects when they can be started, how they are monitored and who may be a suitable candidate.

Buprenorphine/Naloxone (Suboxone)

Suboxone is a brand-name medication containing buprenorphine and naloxone. It is therefore not a separate option from “buprenorphine and naloxone,” as the two terms are sometimes mistakenly presented.

• Buprenorphine is a partial opioid agonist that can help reduce opioid cravings and withdrawal symptoms.
• Naloxone is included in combination formulations such as Suboxone as part of the medication’s design.

Starting buprenorphine/naloxone requires appropriate timing and medical guidance, which is why clients should not attempt to determine dosing or initiation on their own.

Naltrexone

Naltrexone takes a different approach. Rather than acting as an opioid agonist, it blocks opioid receptors, reducing the ability of opioids to produce their usual effects. Because naltrexone and buprenorphine work differently and have different requirements for starting treatment, one cannot simply replace the other without medical evaluation.

There are also other medications for opioid use disorder, but not every provider offers every medication. The options available through Bright Futures and the medication appropriate for a particular client are discussed with the medical team during evaluation.

Medication Decisions Require Medical Oversight

Choosing a medication is not simply a matter of matching a drug to a diagnosis. The medical team also needs to understand what a client has been using, which prescriptions they already take, relevant health conditions and how previous treatments or medications have affected them.

Bright Futures Medical Director Dr. Jeffrey Bishop is board-certified in Family Medicine and holds certification in Addiction Medicine. Kathleen Simervil, PA, brings experience in psychiatric and addiction medicine across detox, residential, partial hospitalization, intensive outpatient and outpatient settings.

Together with the wider Bright Futures treatment team, our medical professionals can evaluate whether medication has a role in treatment, recommend an appropriate option and monitor how the client responds.

Admissions can help begin the process and collect important background information, but qualified medical professionals make the medication selection and prescribing decisions.

How Medication Fits Into the Rest of Treatment

Medication may address cravings, opioid effects or other aspects of OUD, while a client may still be working through the relationships, mental health concerns, triggers and routines surrounding substance use. At Bright Futures, MAT can therefore sit alongside individual and group therapy and other parts of an individualized treatment plan.

Someone may use therapy to work through high-risk situations, rebuild relationships or develop healthier coping strategies while medication addresses another part of the opioid-use disorder. When depression, anxiety, trauma or another mental health condition is also present, care may include treatment for co-occurring disorders as well.

Medication and therapy are not competing approaches. When both have a role, they can address different needs within the same recovery plan.

Where MAT Fits Into PHP and Outpatient Care

MAT is a treatment component rather than a level of care. Receiving medication does not, by itself, determine whether someone belongs in PHP, IOP or general outpatient treatment.

• A client who needs more daytime structure may receive medication while participating in our Partial Hospitalization Program (PHP). Someone who is ready for greater independence may continue medication while attending Intensive Outpatient or general outpatient care.
• For eligible Florida residents, medication management can also be part of our Virtual Intensive Outpatient Program.

This means that treatment can change without medication necessarily changing at the same time. A client may step down from PHP into IOP while continuing the same OUD medication, for example, because the appropriate level of therapy and the appropriate duration of medication answer two different clinical questions.

How Long Does Medication-Assisted Treatment Last?

There is no universal point at which someone should stop an OUD medication simply because another part of treatment has ended. How long medication remains useful can depend on the medication itself, your response, opioid-use history, current stability and the medical team’s recommendations. Some people may use medication for a shorter period. Others may benefit from continuing it longer.

That timeline does not need to match the length of PHP, IOP or outpatient treatment. Completing one level of care is therefore not, by itself, a reason to discontinue medication. Any reduction, change or discontinuation should be discussed with the treating provider. Changing certain medications without medical guidance can create unnecessary risks and may disrupt progress that has already been made.

Monitoring MAT During Treatment

Once medication begins, the focus shifts from choosing an option to understanding how that option is working in everyday treatment. Clients should let the medical team know about side effects, changes in cravings, new prescriptions and meaningful changes in their physical or mental health. These details help the prescribing provider decide whether the current plan should continue or whether something needs to be adjusted. It is also important to share information about prescription medications, over-the-counter products, supplements and other substances being used. Having the complete picture helps the medical team evaluate possible interactions and make safer decisions.

If opioid use returns during MAT, that deserves reassessment rather than an automatic conclusion that treatment has failed. The team can review medication use, safety concerns and what was happening around the return to use, then determine whether medication or another part of the treatment plan should change.

Insurance and Paying for MAT

Insurance coverage for MAT can involve both the medication and the treatment surrounding it. However, insurance plans can handle those benefits in different ways.

Bright Futures currently works with many major insurance providers, including Aetna, Humana, TRICARE, AmeriHealth, Blue Cross Blue Shield, Cigna, Oscar, UMR, AvMed, Optum and UnitedHealthcare.

Actual coverage can vary according to the policy, medication, medical necessity and any authorization requirements. Having insurance through one of these providers does not guarantee that every medication or treatment service will be covered.

You can review insurance accepted at Bright Futures Treatment Center for more information. Our admissions team can also verify insurance benefits before treatment begins and help clarify how the plan applies to recommended care.

Starting MAT at Bright Futures

The first step in MAT is not choosing a medication. We gather information to understand whether medication should be part of the treatment or not. When you contact our admissions team, we begin with a free pre-admission assessment covering substance use, physical and mental health, previous treatment and current circumstances. Admissions specialists are available 24/7, and the initial conversation generally takes about 15 to 20 minutes.

If MAT may have a role in treatment, the next step is medical evaluation. The medical team can review opioid-use history, current prescriptions and other relevant health information before discussing an appropriate medication plan. The goal is not to place every client on medication. It is to determine when medication can support the treatment of opioid use disorder and, when it can, make sure it is prescribed and monitored responsibly.

To ask about Medication-Assisted Treatment in Florida, contact Bright Futures Treatment Center at (844) 207-7772.